UBS analyst AJ Rice raised the firm’s price target on Pediatrix Medical (MD) to $16.50 from $16 and keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MD:
- Pediatrix Medical sees FY25 adjusted EBITDA $245M-$255M
- Pediatrix Medical reports Q2 adjusted EPS 53c, consensus 42c
- Pediatrix Medical Group, Inc. (MD) Q2 Earnings Cheat Sheet
- Cautious Optimism: Evaluating Pediatrix Medical Group Amid Shifting Birth Trends
- Pediatrix Medical Group Appoints Dr. Kurt Newman to Board